Skip to main content
. 2019 Nov 20;25(3):e469–e476. doi: 10.1634/theoncologist.2019-0541

Figure 3.

Figure 3

Kaplan‐Meier curves for comparison of overall survival between patients with metastatic colorectal cancer in the T‐B group and the T group after propensity score matched analysis.Abbreviations: CI, confidence interval; HR, hazard ratio; NA, not applicable because calculation was impossible; OS, overall survival; T group, patients receiving TAS‐102 monotherapy; T‐B group, patients receiving TAS‐102 plus bevacizumab.